Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to putting an end to childhood cancer. Stay up to date with our blog on latest research news, meet our researchers and hear what’s happening in our labs and beyond.
Curing childhood cancer requires global effort. In this new blog series, you’ll meet some of the many national and international partners who are working with us to make it happen. We’ll start with Cancer Therapeutics CRC.
Our researchers have developed a method to measure the amount of copper inside neuroblastoma tumours. Published in the journal Theranostics, it offers a potential tool for treating and monitoring neuroblastoma.
Twenty-six police officers and one cancer researcher took to the skies last Sunday to raise funds for childhood cancer research. The inaugural Great Cop Drop was inspired by Isla, a little girl diagnosed with leukaemia four years ago.
A drug called OBI-3424 has been designated an Orphan Drug by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukaemia, based predominantly on research carried out by our Leukaemia Biology Program.
Ten of our researchers spent a successful and productive two days at the Sydney Cancer Conference at Darling Harbour last week. The work they presented was very well-received, with two speakers carrying off prizes.
September marks Children’s Cancer Awareness Month, a time to bring awareness of the devastating effects of childhood cancer and raise vital funds for research into finding a cure.
To commemorate, Children’s Cancer Institute has engaged in a variety of awareness and fundraising activities throughout the month.
Olivia Lambert was a bright and happy little girl with an infectious smile and a fun-loving spirit. Diagnosed with stage 4 neuroblastoma at age two and a half, she fought the disease bravely for six years. Her legacy and spirit continue with the appointment of Dr Joshua McCarroll as the Olivia Lambert Team Leader.